Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now later-stage tilt small index

Pregnancy in Diabetic: later-stage trial registry

4 of 6 indexed Pregnancy in Diabetic trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Pregnancy in Diabetic: 6 US clinical trials tracked, 4 recruiting.

Pregnancy in Diabetic is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Ohio State University, running 3 of these trials.

Enrollment posture brief

Registry condition pregnancy-in-diabetic

OPEN 4 | RECR 67% | LATE 1 | EARLY 0 | RANK #2866 | SPON 3

Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)

Pregnancy in Diabetic (this)67%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near Pregnancy in Diabetic

Pregnancy in Diabetic lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pregnancy in Diabetic on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pregnancy in Diabetic is recruiting above its size-band peers.

    4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Pregnancy in Diabetic research.

    Ohio State University accounts for 3 of 6 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Typical Pregnancy in Diabetic enrolment sits around 200 participants.

    Median target enrolment is 200 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.

  4. Pregnancy in Diabetic research is mostly interventional.

    5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Pregnancy in Diabetic records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Provider-led Insulin (standard care) Drug
1 trials
Patient-led Insulin (intervention group) Drug
1 trials
Per oral intake of food and drink Behavioral
1 trials
Fasting before gestational diabetes screen Behavioral
1 trials
Standard of care 4-12 week postpartum OGTT Diagnostic test
1 trials
Immediate inpatient postpartum OGTT Diagnostic test
1 trials
Routine Care-RX meter Device
1 trials
iGlucose Smart Meter System Device
1 trials

US sites by state

Facility locations filed on Pregnancy in Diabetic trials. A trial with sites in several states counts in each.

Ohio 4 trials
Texas 1 trials
New York 1 trials
Massachusetts 1 trials
Colorado 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pregnancy in Diabetic page

6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pregnancy in Diabetic condition card totals 6 registered trials; most-linked intervention Provider-led Insulin (standard care); top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.